Merck & Co., Inc. (NEO:MRK)

Canada flag Canada · Delayed Price · Currency is CAD
17.45
+0.31 (1.81%)
May 16, 2025, 4:00 PM EDT
Market Cap 267.16B
Revenue (ttm) 91.88B
Net Income (ttm) 25.06B
Shares Out n/a
EPS (ttm) 9.89
PE Ratio 10.66
Forward PE 8.46
Dividend n/a
Ex-Dividend Date n/a
Volume 11,577
Average Volume 15,412
Open 17.25
Previous Close 17.14
Day's Range 17.06 - 17.45
52-Week Range 16.85 - 22.39
Beta n/a
RSI 40.88
Earnings Date Apr 24, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Cboe Canada
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.